TABLE 3.
Clinical characteristics stratified by DM in patients with low HDLC.
| Before propensity score matching |
After propensity score matching |
|||||
| Non-diabetes group (n = 218) | Diabetes group (n = 59) | p-value | Non-diabetes group (n = 115) | Diabetes group (n = 59) | p-value | |
| Sex | 1.000 | 0.753 | ||||
| Male | 150 (68.8) | 41 (69.5) | 84 (73.0) | 41 (69.5) | ||
| Female | 68 (31.2) | 18 (30.5) | 31 (27.0) | 18 (30.5) | ||
| Age, years | 0.628 | 1.000 | ||||
| ≥60 | 68 (31.2) | 21 (35.6) | 40 (34.8) | 21 (35.6) | ||
| <60 | 150 (68.8) | 38 (64.4) | 75 (65.2) | 38 (64.4) | ||
| BMI, kg/m2 | 0.169 | 1.000 | ||||
| ≥24.0 | 94 (43.1) | 32 (54.2) | 63 (54.8) | 32 (54.2) | ||
| <24.0 | 124 (56.9) | 27 (45.8) | 48 (45.2) | 27 (45.8) | ||
| Extra-hepatic disease | 0.364 | 0.776 | ||||
| Present | 55 (25.2) | 19 (32.2) | 41 (35.7) | 19 (32.2) | ||
| Absent | 163 (74.8) | 40 (67.8) | 74 (64.3) | 40 (67.8) | ||
| Hepatocellular carcinoma | 0.556 | 1.000 | ||||
| Present | 74 (33.9) | 17 (28.8) | 34 (29.6) | 17 (28.8) | ||
| Absent | 144 (66.1) | 42 (71.2) | 81 (70.4) | 42 (71.2) | ||
| Triglycerides, mmol/L | 0.962 | 1.000 | ||||
| High | 25 (11.5) | 6 (10.2) | 11 (9.6) | 6 (10.2) | ||
| Normal | 193 (88.5) | 53 (89.8) | 104 (90.4) | 53 (89.8) | ||
| ALT, IU/L | 0.769 | 0.996 | ||||
| ≥2-fold normal upper limit | 50 (22.9) | 13 (22.0) | 26 (22.6) | 13 (22.0) | ||
| 0–2-fold normal upper limit | 39 (17.9) | 13 (22.0) | 25 (21.7) | 13 (22.0) | ||
| Normal | 129 (59.2) | 33 (55.9) | 64 (55.7) | 33 (55.9) | ||
| AST, IU/L | 0.923 | 0.828 | ||||
| ≥2-fold normal upper limit | 59 (27.1) | 16 (27.1) | 35 (30.4) | 16 (27.1) | ||
| 0–2-fold normal upper limit | 57 (26.1) | 14 (23.7) | 29 (25.2) | 14 (23.7) | ||
| Normal | 102 (46.8) | 29 (49.2) | 51 (44.3) | 29 (49.2) | ||
| MELD score | 0.949 | 0.750 | ||||
| Median | 9.0 | 9.0 | 9.0 | 9.0 | ||
| Interquartile range | 6–13 | 5–14 | 6–14 | 5–14 | ||
| Infection | 0.003 | 0.022 | ||||
| Present | 40 (18.3) | 22 (37.3) | 23 (20.0) | 22 (37.3) | ||
| Absent | 178 (81.7) | 37 (62.7) | 92 (80.0) | 37 (62.7) | ||
Data are presented as the number with percentage or median with interquartile range. ALT, alanine transaminase; AST, aspartate aminotransferase; BMI, body mass index; DM, diabetes mellitus; HDLC, high-density lipoprotein cholesterol; MELD, model for end-stage liver disease.